ÂÜÀòÂÒÂ×

Shuang Liu is the founder and CEO of ConSynance Therapeutics. Shuang previously worked as an integrated project leader in drug discovery at AMRI from June 1998 to September 2014.

Shuang Liu earned a Bachelor of Science in Chemistry from Beijing Normal University, a Ph.D. in Organic Chemistry from The University of Georgia, and did post-doctoral training in organic chemistry at Emory University. Shuang is currently doing graduate study in photochemistry at the University of Chinese Academy of Sciences.

Some individuals on their team include Roman Dvorak - Chief Medical Officer, Lois Rosenberger - Head of Regulatory, and William Bracken - Head of Toxicology.